| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |